Slr Investment Corp. (SLRC) Stock Price & Analysis
Slr Investment Corp. (SLRC) rose 1.18% to USD 12.89 as of June 10, 2026 at 00:51 UTC, according to Nexqual real-time market data.
SLRC last closed at USD 12.74; the session ranged USD 12.79–12.93 on volume of 216,395 shares. Market capitalization is $703.21M, with a 52-week range of USD 12.54–17.1 (NMS). Source: Nexqual, June 10, 2026 at 00:51 UTC.
Key Statistics (as of June 10, 2026 at 00:51 UTC)
| Price | USD 12.89 |
|---|---|
| Change | ▲ 1.18% (up) |
| Previous Close | USD 12.74 |
| Open | USD 12.79 |
| Day Range | USD 12.79 – 12.93 |
| 52-Week Range | USD 12.54 – 17.1 |
| Volume | 216,395 shares |
| Market Cap | $703.21M |
| Exchange | NMS |
Technical Analysis (SLRC)
Nexqual's technical model rates SLRC "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 00:51 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 34.84 (neutral) |
| vs SMA50 | Below (USD 14.3) |
| MACD | -0.39 (negative) |
Analyst Ratings (SLRC)
Wall Street analysts rate SLRC "Buy" based on 8 analysts, with a mean price target of USD 15.56 (range USD 13.5–18), per Nexqual as of June 10, 2026 at 00:51 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 8 |
| Mean Target | USD 15.56 |
| High Target | USD 18 |
| Low Target | USD 13.5 |
| Buy / Hold / Sell | 5 / 2 / 1 |
Earnings (SLRC)
| Next Earnings Date | 2026-08-04 |
|---|---|
| EPS Estimate | USD 0.33 |
| Revenue Estimate | $48.87M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.33 vs est 0.4 ▼ miss |
| 2025-12-31 | USD 0.39 vs est 0.4 ▼ miss |
| 2025-09-30 | USD 0.4 vs est 0.41 ▼ miss |
| 2025-06-30 | USD 0.4 vs est 0.4 ▼ miss |
Source: Nexqual, June 10, 2026 at 00:51 UTC.
Financials & Fundamentals (SLRC)
| Total Revenue | $214.65M |
|---|---|
| Revenue Growth (YoY) | -7.30% |
| Gross Margin | +100.00% |
| Operating Margin | +69.45% |
| Profit Margin | +41.80% |
| ROE | +9.06% |
| Debt / Equity | 114.88 |
| Current Ratio | 1.04 |
| Total Cash | $400.13M |
| Total Debt | $1.14B |
| Free Cash Flow | $-4.63M |
Source: Nexqual, June 10, 2026 at 00:51 UTC.
Financial Health Score (SLRC)
Nexqual rates Slr Investment Corp.'s overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 00:51 UTC.
| Growth | Weak — Revenue -6% YoY (annual), declining |
|---|---|
| Profitability | Strong — Operating margin 69% |
| Balance Sheet | Mixed — $400M cash vs $1.14B debt |
| Cash Flow | Weak — FCF negative: -$5M, burning cash |
| Efficiency | Mixed — ROE 9%, ROA 3.7% |
Ownership (SLRC)
| Insider Ownership | +2.74% |
|---|---|
| Institutional Ownership | +40.65% |
| Shares Outstanding | 54.55M |
| Short % of Float | +1.92% |
Source: Nexqual, June 10, 2026 at 00:51 UTC.
Leadership (SLRC)
Slr Investment Corp. is led by Michael Stuart Gross (age 63), Chairman, President & Co-CEO, per Nexqual as of June 10, 2026 at 00:51 UTC.
| Chairman, President & Co-CEO | Michael Stuart Gross (age 63) |
|---|---|
| Co-CEO, COO & Interested Director | Bruce John Spohler (age 64) |
| CFO & Secretary | Shiraz Y. Kajee (age 45) |
Major Backers & Investors (SLRC)
Notable institutional backers of Slr Investment Corp. include Thornburg Investment Management Inc., JPMorgan, Van Eck Associates Corporation, according to Nexqual as of June 10, 2026 at 00:51 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Thornburg Investment Management Inc. | 16.48% |
| JPMorgan | 2.31% |
| Van Eck Associates Corporation | 1.62% |
| Diameter Capital Partners LP | 1.52% |
| Aristotle Capital Boston, LLC | 1.38% |
| VanEck ETF Trust-VanEck BDC Income ETF | 1.32% |
| UBS Group AG | 1.04% |
| Franklin Resources, Inc. | 1.04% |
Source: Nexqual, June 10, 2026 at 00:51 UTC.
From Slr Investment Corp.'s Latest SEC 10-K Filing (filed 2026-02-24)
Key Strengths & Strategy (as disclosed to the SEC)
- SLR Investment Corp. is a business development company specializing in secured debt (first lien unitranche and second lien), subordinated (unsecured) debt, minority equity, leveraged buyouts, acquisitions, recapitalizations, general refinancing, growth capital and strategic income-oriented control equity investments in leveraged middle market companies.
- It also invests in life sciences with focus on specialty pharmaceuticals, medical devices, biotech, health Care Providers and services; health Care technology, enabling technologies and tools.
- The fund's investments generally range between $5 million and $25million.
- The fund invests in companies with debt investments between $10 million and $50 million with revenues between $50 million and $1000 million and EBITDA between $15 million and $100 million.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PNNT | PennantPark Investment Corporat | USD 3.79 | ▼ 1.81% |
| GBDC | Golub Capital BDC, Inc. | USD 13.1 | ▲ 0.46% |
| FDUS | Fidus Investment Corporation | USD 18.63 | ▲ 0.87% |
| TCPC | BlackRock TCP Capital Corp. | USD 3.68 | ▲ 0% |
| NMFC | New Mountain Finance Corporatio | USD 7.89 | ▲ 0.77% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:51 UTC. This page is informational and not investment advice.